Cargando…

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

Hepatocellular carcinoma (HCC) is a highly vascular tumour that expresses vascular endothelial growth factor (VEGF). Various studies have evaluated the prognostic value of VEGF levels in HCC. Its overall test performance remains unclear, however. The aim was to perform a systematic review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoenleber, S J, Kurtz, D M, Talwalkar, J A, Roberts, L R, Gores, G J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694418/ https://www.ncbi.nlm.nih.gov/pubmed/19401698 http://dx.doi.org/10.1038/sj.bjc.6605017

Ejemplares similares

Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021)

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
por: Tandon, Puneeta, et al.
Publicado: (2009)

Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
por: Kulapaditharom, Boonchu, et al.
Publicado: (2012)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis
por: Rentka, Anikó, et al.
Publicado: (2015)

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
por: Waked, Imam, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
por: Murphy, Brendan P., et al.
Publicado: (2014)

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
por: Ghatalia, P, et al.
Publicado: (2015)

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
por: Nouso, K, et al.
Publicado: (2008)

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
por: Yoshimura, K, et al.
Publicado: (2013)

A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications
por: Kelly, S P, et al.
Publicado: (2011)

Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization
por: Wakabayashi, Taku, et al.
Publicado: (2013)

Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients
por: do Espírito Santo, Gilmar Ferreira, et al.
Publicado: (2017)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
por: Alzamzamy, Ahmed, et al.
Publicado: (2021)

Enhanced Vascular Endothelial Growth Factor Gene Expression in Ischaemic Skin of Critical Limb Ischaemia Patients
por: Bleda, Silvia, et al.
Publicado: (2012)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma
por: He, Kun, et al.
Publicado: (2023)

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration
por: Chalam, Kakarla V., et al.
Publicado: (2014)

Inhibiting Vascular Endothelial Growth Factor in Injured Intervertebral Discs Attenuates Pain-Related Neuropeptide Expression in Dorsal Root Ganglia in Rats
por: Sato, Jun, et al.
Publicado: (2017)

Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD
por: Salter, Brittany M., et al.
Publicado: (2016)

Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration
por: Levy, Adrian R., et al.
Publicado: (2009)

Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
por: Qi, Yuchen, et al.
Publicado: (2023)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma
por: Cescon, Matteo, et al.
Publicado: (2010)

Comparison of Staging Systems of Hepatocellular Carcinoma
por: Sirivatanauksorn, Yongyut, et al.
Publicado: (2011)

Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma
por: Tsai, Hung-Wen, et al.
Publicado: (2018)

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis
por: Thompson Coon, J, et al.
Publicado: (2008)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients
por: Greten, T F, et al.
Publicado: (2005)

Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
por: Lee, J, et al.
Publicado: (2013)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
por: Li, J, et al.
Publicado: (2014)

Time-Dependent Changes of Plasma Concentrations of Angiopoietins, Vascular Endothelial Growth Factor, and Soluble Forms of Their Receptors in Nonsmall Cell Lung Cancer Patients Following Surgical Resection
por: Kopczyńska, Ewa, et al.
Publicado: (2012)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice
por: Bruera, Gemma, et al.
Publicado: (2014)

Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
por: Chang, Pik Eu, et al.
Publicado: (2013)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients
por: Liu, Lei, et al.
Publicado: (2014)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_5p0seq26if9gv2hcae840l946h